Akili Interactive Receives $11,900,000 Series B Funding

  • Feed Type
  • Date
  • Company Name
    Akili Interactive
  • Mailing Address
    501 Boylston Street Boston, MA 02116 USA
  • Company Description
    Transforming healthcare with clinically-validated digital medicine.
  • Website
  • Transaction Type
    Venture Equity
  • Transaction Amount
  • Transaction Round
    Series B
  • Proceeds Purposes
    Akili will use the funds to support and expand clinical development of its clinical-stage products into new areas, with an expanded focus on neurodegeneration, and to build out its commercial infrastructure as Akili nears the market with its late-stage products.
  • M&A Terms
  • Venture Investor
    Merck Capital Ventures
  • Venture Investor
    Amgen Ventures

Trending on Xconomy